SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-19-017226
Filing Date
2019-01-25
Accepted
2019-01-25 17:11:32
Documents
3
Group Members
SV LIFE SCIENCES FUND VI (GP), L.P.SV LIFE SCIENCES FUND VI STRATEGIC PARTNERS, L.P.SV LIFE SCIENCES FUND VI, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D d689880dsc13d.htm SC 13D 98905
2 EX-99.1 d689880dex991.htm EX-99.1 7631
3 EX-99.2 d689880dex992.htm EX-99.2 24423
  Complete submission text file 0001193125-19-017226.txt   132819
Mailing Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139 7819626030
AVROBIO, Inc. (Subject) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90532 | Film No.: 19543259
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SV HEALTH INVESTORS, LLC ONE BOSTON PLC, 201 WASHINGTON ST. #3900 BOSTON MA 02108
Business Address C/O SV HEALTH INVESTORS, LLC ONE BOSTON PLC, 201 WASHINGTON ST. #3900 BOSTON MA 02108 6173678100
SVLSF VI, LLC (Filed by) CIK: 0001717728 (see all company filings)

IRS No.: 473729692 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D